Document Type
Patent
Publication Date
12-6-2016
Patent Number
9511084
CPC
A61K 31/7064 (20130101)
Abstract
This invention encompasses combination therapies including TCN, TCN-P, TCN-PM and/or related compounds and one or more additional anti-cancer agents, for example, taxanes a molecule that modulates the HER2/neu (erbB2) receptor, anthracyclin compounds, epidermal growth factor receptor inhibitor compounds, one or more platinum compounds and bortezomib and derivatives thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Application Number
14/514,311
Recommended Citation
Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and methods of use thereof" (2016). USF Patents. 907.
https://digitalcommons.usf.edu/usf_patents/907
Assignees
University of South Florida
Filing Date
2014-10-14
